SREA insider notice: 28,864 RSU shares to be sold via Oppenheimer
Rhea-AI Filing Summary
Form 144 notice for Sempra (symbol: SREA) shows a proposed sale of 28,864 shares of common stock through Oppenheimer & Co., with an aggregate market value of $2,422,844.16 and an approximate sale date of 09/15/2025. The filing reports that all shares to be sold were acquired primarily through vesting of restricted stock units and reinvested dividends under Sempra's Long-Term Incentive Plan, with acquisition dates ranging from 01/03/2022 through 02/19/2025. The filing lists 652,472,426 shares outstanding, and discloses that there were no securities sold by the filer in the past three months.
Positive
- Full acquisition traceability: All shares to be sold are documented as vested restricted stock units or reinvested dividends under the company's Long-Term Incentive Plan
- Named broker and market value disclosed: Sale to be executed through Oppenheimer with an aggregate market value of $2,422,844.16
- No recent disposals: Filers report "Nothing to Report" for securities sold in the past three months
Negative
- None.
Insights
TL;DR: Routine insider sale of vested RSUs representing a small fraction of outstanding shares; appears procedural rather than a material company event.
The Form 144 documents a planned sale of 28,864 shares with an aggregate market value of $2,422,844.16 to be executed via Oppenheimer on or about 09/15/2025. The securities were acquired through vesting of restricted stock units and reinvested dividends from 2022 through 2025, consistent with compensation-related dispositions. There were no reported sales by the filer in the prior three months, and the shares to be sold represent a negligible percentage of the 652,472,426 shares outstanding. From an equity-impact perspective, this filing is procedural and unlikely to move valuation metrics materially.
TL;DR: Disclosure aligns with Rule 144 requirements; shows transparent reporting of compensation-origin shares and planned broker-assisted sale.
The notice provides the required chain-of-acquisition detail: multiple vesting events and reinvested dividends tied to Sempra's Long-Term Incentive Plan, listing dates and unit counts that sum to the 28,864 shares to be sold. The use of a named broker and the explicit representation that the filer is unaware of undisclosed material adverse information reflect compliance-focused disclosures. This filing documents an individual disposition of compensation-related equity rather than any governance action by the issuer.
FAQ
What does the Form 144 for SREA disclose about the number of shares to be sold?
What is the aggregate market value of the shares listed in the SREA Form 144?
How were the shares being sold acquired according to the filing?
When is the approximate date of sale listed in the Form 144?
Which broker is named to execute the sale in the SREA Form 144?